Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Colorectal Neoplasms 476Carcinoma, Non-Small-Cell Lung 233Breast Neoplasms 196Ovarian Neoplasms 171Glioblastoma 157Carcinoma, Hepatocellular 131Neoplasms 128Rectal Neoplasms 114Colonic Neoplasms 110Neoplasm Metastasis 106Brain Neoplasms 98Lung Neoplasms 96Fallopian Tube Neoplasms 85Carcinoma, Renal Cell 77Glioma 69Pancreatic Neoplasms 54Liver Neoplasms 44Melanoma 43Gliosarcoma 43Uterine Cervical Neoplasms 40Adenocarcinoma of Lung 39Stomach Neoplasms 37Recurrence 33Astrocytoma 30Carcinoma, Ovarian Epithelial 28Endometrial Neoplasms 27Triple Negative Breast Neoplasms 26Kidney Neoplasms 23Prostatic Neoplasms 22Esophageal Neoplasms 21

Interventions

Mitotane 10Cisplatin 9pembrolizumab 7Doxorubicin 6Etoposide 5Specimen Handling 4Nivolumab 4Magnetic Resonance Spectroscopy 4relacorilant 3cabozantinib 3Cytoreduction Surgical Procedures 3sodium thiosulfate 2cixutumumab 2cemiplimab 2camrelizumab 2apatinib 2Trastuzumab 2Suramin 2Radiotherapy 2Ipilimumab 2Dichlorodiphenyldichloroethane 2Cyclophosphamide 2tipifarnib 1pegfilgrastim 1milademetan 1lenvatinib 1iodophenyl metomidate 1gossypol acetic acid 1fludarabine phosphate 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adrenocortical Carcinoma × Bevacizumab × Clear all
NCT00469469 2015-04-22

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

Dartmouth-Hitchcock Medical Center

Phase 2 Withdrawn
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡